Bryn (BRRN) Research & Development (2011 - 2012)
Bryn (BRRN) posted Research & Development of $90862.0 for Q4 2012, down 52.26% on a QoQ basis from $190314.0 in Q3 2012, and down 18.64% year-over-year from $111680.0 in Q4 2011.
Powered by 
Analysis
Bryn (BRRN) Research & Development (2011 - 2012) Analysis & Trends
Bryn has reported Research & Development for 2 years, with the latest figure at $90862.0 in Q4 2012.
- On a quarterly basis, Research & Development fell 18.64% year-over-year to $90862.0 in Q4 2012; TTM through Oct 2012 was $580873.0, a 153.82% increase from a year earlier, with the FY2012 full-year figure at $460055.0, up 591.67% from the prior year.
- Research & Development was $90862.0 for Q4 2012 at Bryn, down from $190314.0 in the prior quarter.
- The five-year high for Research & Development was $190314.0 in Q3 2012, with the low at $9247.0 in Q1 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 42.45 Bn | 35.21 Bn | 695.95 Mn | 222.92 Mn |
| 2 | Doximity | 4.53 Bn | 3.84 Bn | 132.93 Mn | 45.05 Mn |
| 3 | Waystar Holding | 4.42 Bn | 4.23 Bn | 221.99 Mn | 50.38 Mn |
| 4 | CCC Intelligent Solutions Holdings | 3.92 Bn | 3.81 Bn | 210.64 Mn | 52.99 Mn |
| 5 | Schrodinger | 1.40 Bn | 987.50 Mn | 32.43 Mn | 41.00 Mn |
| 6 | EverCommerce | 1.15 Bn | 1.02 Bn | 119.50 Mn | 33.72 Mn |
| 7 | Certara | 1.14 Bn | 959.65 Mn | 58.15 Mn | 14.98 Mn |
| 8 | GoodRx Holdings | 1.13 Bn | 838.77 Mn | 179.41 Mn | 81.99 Mn |
| 9 | Healthstream | 845.04 Mn | 778.31 Mn | 54.72 Mn | 13.58 Mn |
| 10 | Bryn | 162.00 Mn | 162.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2012 | 90,862.00 |
| Jul 31, 2012 | 190,314.00 |
| Apr 30, 2012 | 145,805.00 |
| Jan 31, 2012 | 153,892.00 |
| Oct 31, 2011 | 111,680.00 |
| Jul 31, 2011 | 50,659.00 |
| Apr 30, 2011 | 57,267.00 |
| Jan 31, 2011 | 9,247.00 |